Dr. Burzynski is a physician and investigator recognized for pioneering the use of biologically active peptides for cancer treatment. He holds both MD and PhD degrees and has extensive experience in targeted agents, immunotherapy, and phenylbutyrate for cancer. His research focuses on antineoplastons, investigational agents derived from his early work on naturally occurring human peptides.
Is this your profile? Register to manage your profile, complete your details, publish articles and receive client inquiries.
Claim this profile →